The White House’s fiscal 2013 budget request reflects FDA’s emphasis on more collaboration with other countries as the only workable long-term approach to ensuring global drug production quality, but also underscores that the agency wants more of its own inspectors on the scene in China.
The Obama administration’s request targets the increase in budget authority – money provided from the general Treasury rather than from user fees – for pharmaceutical programs to boost the number...